Draft guidance maps review process for 510(k) submissions

The FDA has released draft guidance outlining the process for reviewing low-risk medical devices seeking approval under the 510(k) program. The guidance is up for comment through April 26. The Hill/Healthwatch blog

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: